Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permethrin 2.5% plus tea tree oil gel for papulopustular rosacea with Demodex infestation
IRCT20140304016837N4Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Apr 2017
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rosacea and papulopustular rosacea comparing Permethrin 2.5% + tea tree oil gel with Placebo gel (2 arms). Primary endpoints: Density of Demodex mite, Rosacea primary symptoms and 1 more. Started Apr 2017; status: completed.
02
Drugs
permethrinTea tree oil
03
Conditions
rosaceapapulopustular rosacea
Beyond the preview
Go deeper on IRCT20140304016837N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140304016837N4.